Discover Leading Defense Technology Solutions
Discover cutting-edge solutions from leading global suppliersAdvanced personal telemedicine solutions provider SHL Telemedicine Ltd. has successfully showcased its SmartHeart® portable 12-lead ECG technology during the US Army’s Project Convergence – Capstone 4 (PC-C4) experiment.
PC-C4 is a joint, multinational experiment hosted by the U.S. Army across multiple locations in February and March, allowing military medicine to explore and integrate the latest technological innovations in a field environment.
One key event during the experiment was a comprehensive multi-day army medical experiment held at Fort Irwin’s National Training Center in the Mojave Desert amidst the challenging terrains of California’s Tiefort Mountains.
Designed to revolutionize urgent cardiovascular assessment in non-traditional settings, SmartHeart® provided critical support across different roles of care, during the experiments, ensuring swift and accurate heart condition evaluations in various levels of trauma care.
The SmartHeart® technology was used by a varied group of healthcare clinicians including nurses, medics and physicians amidst the rugged desert conditions, where it demonstrated its reliability, ease of use and effectiveness in extreme conditions.
SmartHeart’s inclusion in this prestigious experiment underscores the growing recognition of SHL’s portable ECG technology as a game-changer in the fast-paced and demanding field of military telehealth technology.
Jason Bottiglieri, General Manager at SHL Telemedicine USA, emphasized the significance of this achievement, stating: “The army’s invitation for SHL to participate and the SmartHeart’s exemplary performance in PC-C4 solidifies our technology’s critical role in rapid cardiac assessment.
“It addresses a crucial need in the continuum of military medical care from initial non-battle evaluation to trauma response, to advanced interventions for intensive and continual care. The SmartHeart’s robust performance in the challenging operational and environmental conditions of the experiment promises to transform how heart conditions are assessed and managed in field operations, ultimately leading to better outcomes for those serving on the front lines.”
